Watson, O. J. et al. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect. Dis. 22, 1293–1302 (2022).Article
CAS
Google Scholar
Meslé, M. M. I. et al. Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021. Euro Surveill. 26, 2101021 (2021).Article
Google Scholar
Larson, H. J., Gakidou, E. & Murray, C. J. L. The vaccine-hesitant moment. N. Engl. J. Med. 386, 58–65 (2022).Article
Google Scholar
World Health Organization. Ten threats to global health in 2019. https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019 (2019).Lazarus, J. V. et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat. Med. 27, 225–228 (2020).Article
Google Scholar
Lazarus, J. V. et al. Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021. Nat. Commun. 13, 3801 (2022).Article
CAS
Google Scholar
Shakeel, C. S., Mujeeb, A. A., Mirza, M. S., Chaudhry, B. & Khan, S. J. Global COVID-19 vaccine acceptance: a systematic review of associated social and behavioral factors. Vaccines (Basel) 10, 110 (2022).Article
CAS
Google Scholar
Wang, Y., McKee, M., Torbica, A. & Stuckler, D. Systematic literature review on the spread of health-related misinformation on social media. Soc. Sci. Med. 240, 112552 (2019).Article
Google Scholar
Pierri, F. et al. Online misinformation is linked to early COVID-19 vaccination hesitancy and refusal. Sci. Rep. 12, 5966 (2022).Article
CAS
Google Scholar
Our World in Data. Coronavirus (COVID-19) vaccinations. https://ourworldindata.org/covid-vaccinationsHassan, M. A. K. & Aliyu, S. Delayed access to COVID-19 vaccines: a perspective on low-income countries in Africa. Int. J. Health Serv. 52, 323 (2022).Article
Google Scholar
Singh, J. A. et al. WHO guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: ethical considerations. Vaccine 40, 2140–2149 (2022).Article
CAS
Google Scholar
Levin, E. G. et al. Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months. N. Engl. J. Med. 385, e84 (2021).Article
CAS
Google Scholar
Chenchula, S., Karunakaran, P., Sharma, S. & Chavan, M. Current evidence on efficacy of COVID-19 booster dose vaccination against the Omicron variant: a systematic review. J. Med. Virol. 94, 2969–2976 (2022).Article
CAS
Google Scholar
MacDonald, N. E. & SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine 33, 4161–4164 (2015).Article
Google Scholar
Schmid, P., Rauber, D., Betsch, C., Lidolt, G. & Denker, M. L. Barriers of influenza vaccination intention and behavior—a systematic review of influenza vaccine hesitancy, 2005–2016. PLoS ONE 12, e0170550 (2017).Article
Google Scholar
Nguyen, K. H. et al. Who has not been vaccinated, fully vaccinated, or boosted for COVID-19. Am. J. Infect. Control 50, 1185–1189 (2022).Article
CAS
Google Scholar
Zhang, Y., Banga Ndzouboukou, J. L., Gan, M., Lin, X. & Fan, X. Immune evasive effects of SARS-CoV-2 variants to COVID-19 emergency used vaccines. Front. Immunol. 12, 4842 (2021).
Google Scholar
Wang, C. Y. et al. A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants. J. Clin. Invest. 132, e157707 (2022).Article
CAS
Google Scholar
Petherick, A. et al. A worldwide assessment of changes in adherence to COVID-19 protective behaviours and hypothesized pandemic fatigue. Nat. Hum. Behav. 5, 1145–1160 (2021).Article
Google Scholar
Levin-Zamir, D. Communication, health literacy and a systems approach for mitigating the COVID-19 pandemic: the case for massive vaccine roll-out in Israel. J. Health Commun. 25, 816–818 (2020).Article
Google Scholar
Choukou, M. A. et al. COVID-19 infodemic and digital health literacy in vulnerable populations: a scoping review. Digit. Health 8, 20552076221076927 (2022).Schwarzinger, M., Watson, V., Arwidson, P., Alla, F. & Luchini, S. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Health 6, e210–e221 (2021).Article
Google Scholar
National Institutes of Health. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. https://www.covid19treatmentguidelines.nih.gov/ (National Institutes of Health, 2022).Ciotti, M., Ciccozzi, M., Pieri, M. & Bernardini, S. The COVID-19 pandemic: viral variants and vaccine efficacy. Crit. Rev. Clin. Lab. Sci. 59, 66–75 (2022).Article
CAS
Google Scholar
The World Bank. Population, total—Brazil, Canada, China, Ecuador, France, Germany, Ghana, India, Italy, Kenya, Mexico, Nigeria, Peru, Poland, Russian Federation, South Africa, Korea, Rep., Singapore, Spain, Sweden, Turkiye, United Kingdom, United States. https://data.worldbank.org/indicator/SP.POP.TOTL?locations=BR-CA-CN-EC-FR-DE-GH-IN-IT-KE-MX-NG-PE-PL-RU-ZA-KR-SG-ES-SE-TR-GB-US (2022).Lounis, M., Bencherit, D., Rais, M. A. & Riad, A. COVID-19 vaccine booster hesitancy (VBH) and its drivers in Algeria: national cross-sectional survey-based study. Vaccines (Basel) 10, 621 (2022).Article
CAS
Google Scholar
Machida, M. et al. Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study. Hum. Vaccin. Immunother. 18, 2086773 (2022).Batra, K., Sharma, M., Dai, C. L. & Khubchandani, J. COVID-19 booster vaccination hesitancy in the United States: a multi-theory-model (MTM)-based national assessment. Vaccines (Basel) 10, 758 (2022).Article
CAS
Google Scholar
Wong, L. P. et al. Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia. Hum. Vaccin. Immunother. 2078634 (2022).Yadete, T. et al. Assessing acceptability of COVID-19 vaccine booster dose among adult Americans: a cross-sectional study. Vaccines (Basel) 9, 1424 (2021).Article
CAS
Google Scholar
Wang, R. et al. The association between social media us …